Correlation of HER2 expression and clinicopathological characteristics in patients with urothelial carcinoma in China

Correlation of HER2 expression and clinicopathological characteristics in patients with urothelial carcinoma in China

Background and purpose: Human epidermal growth factor receptor 2 (HER2) is closely associated with drug efficacy and prognosis in urothelial carcinoma (UC). HER2 is a significant biomarker and therapeutic target in various tumors. In recent years, anti-HER2 antibody-drug conjugates have shown signif...

Full description

Saved in:

Bibliographic Details
Main Author:	WANG Shanshan, YE Dingwei, YANG Li, CHENG Fan, YANG Tiejun, ZHANG Xiaoping, YU Zhixian, ZHANG Qingyun, YANG Yong
Format:	Article
Language:	English
Published:	Editorial Office of China Oncology 2024-11-01
Series:	Zhongguo aizheng zazhi
Subjects:	\|urothelial carcinoma\|human epidermal growth factor receptor 2\|clinicopathological characteristics\|china
Online Access:	http://www.china-oncology.com/fileup/1007-3639/PDF/1733904217468-1023638791.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Distribution and clinicopathological characteristics of G-CSF expression in tumor cells and stromal cells in upper tract urothelial carcinoma
by: Go Kobayashi, et al.
Published: (2024-12-01)

Clinical significance of HER2 in urothelial carcinoma and analysis of its correlation with glycolytic metabolic characteristics
by: Andong Guo, et al.
Published: (2024-12-01)

The Evaluation of CD10 and HER2 Immunohistochemical Markers in Urothelial Carcinoma of Urinary Bladder
by: Khalid W. Abdulfattah Khattab, et al.
Published: (2024-12-01)

Sulfatase modifying factor 2 as a predictive biomarker for urothelial carcinoma
by: Wei-Ting Kuo, et al.
Published: (2025-02-01)

Analysis of the Clinicopathological Characteristics, Genetic Phenotypes, and Prognostics of Primary Pulmonary and Bronchial Adenoid Cystic Carcinoma
by: Zhengyang Hu, et al.
Published: (2025-01-01)

Plasmacytoid urothelial carcinoma with duodenal metastasis—A rare tumor with unusual site of metastasis with grim outcome
by: Aparna Chenniappan, et al.
Published: (2023-01-01)

Recognition of HER2 expression in hepatocellular carcinoma and its significance in postoperative tumor recurrence
by: Ji‐Hua Shi, et al.
Published: (2019-03-01)

Repurposing of Metformin to Improve Survival Outcomes in Patients With Upper Tract Urothelial Carcinoma
by: Hsiang Ying Lee, et al.
Published: (2025-01-01)

Pathological features and immunohistochemical characteristics of clear cell (glycogen-rich) urothelial carcinoma: a case report and systematic review of the literature
by: Weiming Wang, et al.
Published: (2025-02-01)

Dramatic Response to Enfortumab Vedotin in Soft-tissue Metastases from Urothelial Carcinoma: A Case Report
by: Ming-Hsuan Wu, et al.
Published: (2024-12-01)

Reduced p63 expression is linked to unfavourable prognosis in muscle‐invasive urothelial carcinoma of the bladder
by: Kira Furlano, et al.
Published: (2024-11-01)

Predictive role of ABC transporters in the efficacy of enfortumab vedotin for urothelial carcinoma
by: Toshiki Kijima, et al.
Published: (2025-01-01)

Invasive micropapillary urothelial carcinoma of the renal pelvis presenting as nonfunctional kidney: A unique presentation and review of the literature
by: Mohammed Shahin, et al.
Published: (2024-12-01)

Molecular Subtypes of Breast Carcinoma and Their Association with Clinicopathological Features
by: Ambreen Bari, et al.
Published: (2025-01-01)

Clinicopathological and molecular characteristics of papillary thyroid carcinoma in adolescent and young adult patients
by: Van Phu Thang Nguyen, et al.
Published: (2025-02-01)

Retrospective analysis of disease characteristics and treatment patterns among patients with esophageal cancer across 14 surgically represented centers
by: Zhihao Lu, et al.
Published: (2024-12-01)

New Trends and Future Perspectives in the Diagnosis of Urothelial Carcinoma: A Comprehensive Review of the Literature
by: Mourmouris Panagiotis, et al.
Published: (2025-01-01)

Performance of ChatGPT in providing patient information about upper tract urothelial carcinoma
by: Jan Łaszkiewicz, et al.
Published: (2024-07-01)

Clinicopathological characteristics and long-term prognosis of triple-negative breast cancer patients with HER2-Low expression: a retrospective propensity score-matched cohort study
by: Xin Liu, et al.
Published: (2024-12-01)

Novel combination therapy for platinum-eligible patients with locally advanced or metastatic urothelial carcinoma: a systematic review and network meta-analysis
by: Takafumi Yanagisawa, et al.
Published: (2025-02-01)

Comparison of fluorescence in situ hybridization (FISH) and urine cytology in diagnosing urothelial carcinoma: a single-center retrospective cohort study
by: WANG Zhiting, et al.
Published: (2024-12-01)

Expression of EZH2 and H3K27me3 predicts tumor biology of urothelial carcinoma
by: Rasheeda Mohamedali, et al.
Published: (2023-07-01)

Targeting of the HER2/HER3 signaling axis overcomes ligand‐mediated resistance to trastuzumab in HER2‐positive breast cancer
by: Satomi Watanabe, et al.
Published: (2019-03-01)

Effectiveness and safety of PD-1/L1 inhibitors as first-line therapy for patients with advanced or metastatic urothelial carcinoma who are ineligible for platinum-based chemotherapy: a meta-analysis
by: Weiming Liang, et al.
Published: (2025-02-01)

Clinicopathological characteristics of placental chorioangioma: A clinicopathological study of 30 cases
by: Yuanyin Zheng, et al.
Published: (2024-12-01)

FAN score predicts prognosis after platinum-based first-line chemotherapy in patients with metastatic urothelial carcinoma
by: Yu Ishizuya, et al.
Published: (2025-02-01)

Prognostic and clinicopathological significance of mucin family members expression in gastric cancer: a meta-analysis
by: Shunda Wang, et al.
Published: (2025-01-01)

Clinical and molecular analysis of JCPyV and BKPyV infection and associated risk of urothelial carcinoma development in the upper tract
by: Chun-Nun Chao, et al.
Published: (2025-02-01)

HER2 expression and pathway status in male breast cancer patients: results of an integrated analysis among 6,150 patients
by: Boqiang Lyu, et al.
Published: (2025-01-01)

Clinicopathological, Histopathological, and Immunohistochemical Analysis of Mandibular Fibrosarcoma in a DSH Cat: A Case Report
by: Mahmood Ahmadi‐hamedani, et al.
Published: (2024-11-01)

Predicting recurrence of non-muscle invasive bladder urothelial carcinoma: predictive value of the optimal cut-off value of Ki67
by: Rende Peng, et al.
Published: (2025-01-01)

Clinicopathological analysis of sclerosing angiomatoid nodular transformation in the spleen
by: Shufei Wei, et al.
Published: (2023-07-01)

Case report: A rare case of delayed drug-induced hyponatremia in recurrent upper tract urothelial carcinoma following GC and Tislelizumab treatment
by: Zhi-Jie Wang, et al.
Published: (2025-01-01)

Papillary urothelial neoplasm of low malignant potential with osseous metaplasia in a 19-year-old chronic smoker: A case report with review of literature
by: Rakesh K. Gupta, et al.
Published: (2022-05-01)

A Real-World Comparison Between Adjuvant Docetaxel with Cyclophosphamide (TC) and Anthracycline–Taxane Chemotherapy in Early HER-2 Negative Breast Cancer
by: Danilo Giffoni de Mello Morais Mata, et al.
Published: (2024-12-01)

Effectiveness and safety of pembrolizumab, nivolumab, and atezolizumab as adjuvant therapy for high-risk muscle-invasive urothelial carcinoma: an indirect comparison
by: Wei Chen, et al.
Published: (2025-01-01)

Effect of KRAS mutation status on clinicopathological characteristics and overall survival in patients with rectal cancer
by: Shengbin Zheng, et al.
Published: (2025-01-01)

Loss of MTAP expression is strongly linked to homozygous 9p21 deletion, unfavorable tumor phenotype, and noninflamed microenvironment in urothelial bladder cancer
by: Natalia Gorbokon, et al.
Published: (2025-01-01)

Clinicopathological relationship between PM2.5 exposure and acute exacerbations of chronic obstructive pulmonary disease
by: Anfeng Cui, et al.
Published: (2025-02-01)

Gut microbial subtypes and clinicopathological value for colorectal cancer
by: Shuwen Han, et al.
Published: (2024-09-01)